Clinical Trial Update: Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU) [Phase 2]

View source ↗

Summary

A Phase 2a, multi-center randomized trial evaluating the safety and efficacy of topical PEP-TISSEEL for diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• PEP-TISSEEL

Snippet

Sponsor: Rion Inc. | Conditions: Diabetic Foot Ulcer | Phase 2 | Status: COMPLETED